tiprankstipranks
Trending News
More News >
Biontech Se Sponsored Adr (BNTX)
:BNTX
US Market

BioNTech SE (BNTX) Income Statement

Compare
4,600 Followers

BioNTech SE Income Statement

Last quarter (Q1 2025), BioNTech SE's total revenue was €182.80M, a decrease of -2.56% from the same quarter last year. In Q1, BioNTech SE's net income was €-415.80M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.75B€ 3.82B€ 17.31B€ 18.98B€ 482.30M
Gross Profit
€ 2.21B€ 3.22B€ 14.32B€ 16.07B€ 423.00M
Operating Expenses
€ 3.52B€ 2.53B€ 1.67B€ 781.40M€ 505.40M
Depreciation and Amortization
€ 298.00M€ 183.40M€ 123.30M€ 78.20M€ 36.10M
EBITDA
€ -367.10M€ 1.38B€ 12.86B€ 15.00B€ -105.10M
Operating Income
€ -1.31B€ 690.40M€ 12.64B€ 15.28B€ -82.40M
Other Income/Expenses
€ 636.60M€ 495.70M€ 311.40M€ -237.40M€ -63.40M
Pretax Income
€ -677.70M€ 1.19B€ 12.95B€ 15.05B€ -145.80M
Net Income
€ -665.30M€ 930.30M€ 9.43B€ 10.29B€ 15.20M
Per Share Metrics
Basic EPS
€ -2.77€ 3.87€ 38.78€ 42.18€ 0.06
Diluted EPS
€ -2.77€ 3.83€ 37.77€ 39.63€ 0.06
Weighted Average Shares Outstanding
240.18M 240.60M 243.30M 244.00M 253.30M
Weighted Average Shares Outstanding (Diluted)
240.18M 242.70M 249.80M 259.70M 253.30M
Currency in EUR

BioNTech SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis